全文获取类型
收费全文 | 2470篇 |
免费 | 127篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 52篇 |
妇产科学 | 50篇 |
基础医学 | 329篇 |
口腔科学 | 64篇 |
临床医学 | 186篇 |
内科学 | 646篇 |
皮肤病学 | 121篇 |
神经病学 | 157篇 |
特种医学 | 38篇 |
外科学 | 320篇 |
综合类 | 64篇 |
预防医学 | 206篇 |
眼科学 | 48篇 |
药学 | 211篇 |
中国医学 | 21篇 |
肿瘤学 | 93篇 |
出版年
2023年 | 20篇 |
2022年 | 32篇 |
2021年 | 72篇 |
2020年 | 43篇 |
2019年 | 66篇 |
2018年 | 70篇 |
2017年 | 43篇 |
2016年 | 57篇 |
2015年 | 54篇 |
2014年 | 83篇 |
2013年 | 91篇 |
2012年 | 140篇 |
2011年 | 142篇 |
2010年 | 92篇 |
2009年 | 76篇 |
2008年 | 114篇 |
2007年 | 128篇 |
2006年 | 116篇 |
2005年 | 128篇 |
2004年 | 109篇 |
2003年 | 74篇 |
2002年 | 91篇 |
2001年 | 49篇 |
2000年 | 53篇 |
1999年 | 48篇 |
1998年 | 16篇 |
1997年 | 21篇 |
1996年 | 18篇 |
1995年 | 17篇 |
1992年 | 45篇 |
1991年 | 27篇 |
1990年 | 42篇 |
1989年 | 30篇 |
1988年 | 28篇 |
1987年 | 36篇 |
1986年 | 26篇 |
1985年 | 21篇 |
1984年 | 16篇 |
1983年 | 14篇 |
1979年 | 23篇 |
1978年 | 13篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1974年 | 16篇 |
1973年 | 17篇 |
1972年 | 21篇 |
1970年 | 20篇 |
1969年 | 16篇 |
1968年 | 16篇 |
1966年 | 11篇 |
排序方式: 共有2615条查询结果,搜索用时 15 毫秒
71.
72.
Timothy J. Revett Glen B. Baker Jack Jhamandas Satyabrata Kar 《Journal of psychiatry & neuroscience : JPN》2013,38(1):6-23
Alzheimer disease is the most prevalent form of dementia globally and is characterized premortem by a gradual memory loss and deterioration of higher cognitive functions and postmortem by neuritic plaques containing amyloid β peptide and neurofibrillary tangles containing phospho-tau protein. Glutamate is the most abundant neurotransmitter in the brain and is essential to memory formation through processes such as long-term potentiation and so might be pivotal to Alzheimer disease progression. This review discusses how the glutamatergic system is impaired in Alzheimer disease and how interactions of amyloid β and glutamate influence synaptic function, tau phosphorylation and neurodegeneration. Interestingly, glutamate not only influences amyloid β production, but also amyloid β can alter the levels of glutamate at the synapse, indicating that small changes in the concentrations of both molecules could influence Alzheimer disease progression. Finally, we describe how the glutamate receptor antagonist, memantine, has been used in the treatment of individuals with Alzheimer disease and discuss its effectiveness. 相似文献
73.
Rakhee Kar Sarah Grace Priyadarshini M. Niraimathi Debdatta Basu Bhawana Ashok Badhe 《Indian journal of hematology & blood transfusion》2012,28(3):170-174
Plasma cell leukemia (PCL) represents a rare and aggressive form of plasma cell dyscrasia which can be primary (pPCL) or secondary (sPCL). It is diagnosed based on absolute plasma cell count of more than 2.0 × 109/l or a relative proportion of greater than 20% of the peripheral blood leukocyte count. Although pPCL and sPCL share several clinical features, important differences exist. Patients with pPCL are younger; often have extra osseous organ involvement (liver, spleen and other extramedullary sites), increased frequency of renal failure, fast declining performance status and rapid progression to the terminal stage. Patients with sPCL have advanced bone disease. Presented in this article is India data of a short series of five cases of PCL diagnosed at a tertiary care centre from south India over last 5 years. All cases were de novo and had varied spectrum of presentation and so were not suspected to be plasma cell dyscrasia clinically. Detailed hemato-pathological evaluation clinched the diagnosis in all the cases. 相似文献
74.
Acute coronary syndromes (ACS) cause cessation of myocardial blood flow leading to coronary ischemia. The standard medical treatment includes heparin or low molecular weight heparin in the hospital, antiplatelet agents in the hospital and long term, and occasionally warfarin long term. All of these therapies are associated with bleeding complications. Furthermore, warfarin, with its narrow therapeutic window and need for frequent laboratory monitoring, poses several disadvantages. The development of novel oral factor Xa inhibitors and oral direct thrombin inhibitors may provide an alternative to warfarin. In this review, we discuss the new agents, rivaroxaban, apixaban, and dabigatran, for the potential treatment of ACS. We also review the relevant clinical trials evaluating their effects in ACS. These novel anticoagulants allow convenience of use with no requirement for laboratory monitoring and limited drug interactions, which may provide multifaceted treatment options for ACS and anticoagulation in the future. 相似文献
75.
76.
77.
Chantal Loirat Fadi Fakhouri Gema Ariceta Nesrin Besbas Martin Bitzan Anna Bjerre Rosanna Coppo Francesco Emma Sally Johnson Diana Karpman Daniel Landau Craig B Langman Anne-Laure Lapeyraque Christoph Licht Carla Nester Carmine Pecoraro Magdalena Riedl Nicole C. A. J. van de Kar Johan Van de Walle Marina Vivarelli Véronique Frémeaux-Bacchi for HUS International 《Pediatric nephrology (Berlin, Germany)》2016,31(1):15-39
78.
79.
80.
Srinivas U Pillai L Kar R Mahapatra M Gujra S Pati HP 《Indian journal of pathology & microbiology》2007,50(4):917-919
Non-hematopoietic malignancies infiltrating bone marrow have always been a source of erroneous diagnosis. Among these, the small round cell tumors like neuroblastomas and rhabdomyosarcomas mimick the hematopoietic blasts. Several case reports of rhabdomyosarcoma mimicking acute leukemia, clinically and morphologically at presentation have been reported in the literature. To the best of our knowledge such an entity has not been reported in Indian literature. We report here one such case of alveolar rhabdomyosarcoma masquerading as acute leukemia. A thorough clinical examination with high degree of suspicion on bone marrow morphology and judicious use of appropriate immunohistochemistry markers will solve many of these cases. 相似文献